Top compounds associated with response to RP11-327P2.7


Feature Type Standardized
Nominal ANOVA
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.073 0.05
mRNA MS-275 CTRPv2 pan-cancer AAC 0.063 0.05
mRNA Erlotinib gCSI pan-cancer AAC -0.12 0.05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.05
mRNA cabozantinib CTRPv2 pan-cancer AAC -0.071 0.06
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.072 0.06
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.07
mRNA PX-12 CTRPv2 pan-cancer AAC 0.052 0.07
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.066 0.07
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.07
Download CSV